Jul 27, 2020
Pascal Descargues PhD, Founder and CEO, Genoskin talks about bringing the only living injectable human platform to the market to enable clinical testing of drugs for efficacy and toxicity by biotech and pharmaceutical companies. Their standardized platform uses real human skin tissue to test the consequences of drugs administered topically or injected in the skin. Currently Genoskin is also looking at using their platform to test the immunological signature induced by a COVID-19 vaccine candidate to predict if a vaccine can be effective.
@genoskin #genoskin #skin #drugtesting #vaccines #clinicaltesting